Browsing byAuthorHofman, MS

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
2021-08-09Advanced prostate cancer experimental radioactive treatment-clinical trial decision making: patient experiences.Viljoen, B; Hofman, MS; Chambers, SK; Dunn, J; Dhillon, H; Davis, ID; Ralph, N
2023-12-06Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer.Buteau, JP; Moon, D; Fahey, MT; Roberts, MJ; Thompson, J; Murphy, DG; Papa, N; Mitchell, C; De Abreu Lourenco, R; Dhillon, HM; Kasivisvanathan, V; Francis, RJ; Stricker, P; Agrawal, S; O'Brien, J; McVey, A; Sharma, G; Levy, S; Ayati, N; Nguyen, A; Lee, S-F; Pattison, DA; Sivaratnam, D; Frydenberg, M; Du, Y; Titus, J; Lee, S-T; Ischia, J; Jack, G; Hofman, MS; Emmett, L
2022Experiences of participants in a clinical trial of a novel radioactive treatment for advanced prostate cancer: A nested, qualitative longitudinal study.Viljoen, B; Hofman, MS; Chambers, SK; Dunn, J; Dhillon, HM; Davis, ID; Ralph, N
2020-12-16Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial.de Feria Cardet, RE; Hofman, MS; Segard, T; Yim, J; Williams, S; Francis, RJ; Frydenberg, M; Lawrentschuk, N; Murphy, DG; De Abreu Lourenco, R
2018-11-01A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocolHofman, MS; Murphy, DG; Williams, SG; Nzenza, T; Herschtal, A; De Abreu Lourenco, R; Bailey, DL; Budd, R; Hicks, RJ; Francis, RJ; Lawrentschuk, N
2023-08-21The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy.Roberts, MJ; Conduit, C; Davis, ID; Effeney, RM; Williams, S; Martin, JM; Hofman, MS; Hruby, G; Eapen, R; Gianacas, C; Papa, N; Lourenço, RDA; Dhillon, HM; Allen, R; Fontela, A; Kaur, B; Emmett, L; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP),
2018-10-23TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1112 Oncology and CarcinogenesisSiva, S; Chesson, B; Bressel, M; Pryor, D; Higgs, B; Reynolds, HM; Hardcastle, N; Montgomery, R; Vanneste, B; Khoo, V; Ruben, J; Lau, E; Hofman, MS; De Abreu Lourenco, R; Sridharan, S; Brook, NR; Martin, J; Lawrentschuk, N; Kron, T; Foroudi, F